Ke Zhang, Li Jiang, Zhe Jia, Liang Li Bao, Yan Lu, Yi Mu
Department of Hepatobiliary Surgery, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
J Coll Physicians Surg Pak. 2014 Nov;24(11):820-4.
To validate a cheaper and more accessible flow cytometry-based method of assessing Asialoglycoprotein Receptor (ASGPR) expression for hepatic functional reserve.
A retrospective analysis.
Beijing Ditan Hospital, Capital Medical University, Beijing, from January 2011 to October 2013.
Patients with Hepatocellular Carcinoma (HCC) undergoing major hepatectomy at Beijing Ditan Hospital, during the study period were retrospectively studied. The fraction of hepatocytes expressing ASGPR in liver tissues was assessed by flow cytometry. Patients were grouped according to the presence or absence of postoperative hepatic dysfunction. The correlation between ASGPR expression and pre-operative liver function parameters with the outcomes of hepatectomy were analyzed.
Fewer hepatocytes from patients with postoperative hepatic dysfunction expressed ASGPR [63.3 (57.3 - 68.2)] than from patients without postoperative hepatic dysfunction [72.4 (70.6 - 76.3), p < 0.001]. Multiple logistic regression demonstrated ASGPR levels to be independently correlated with postoperative hepatic dysfunction (Odds ratio 3.34, 95% CI: 2.61-6.02, p < 0.001), and the Receiver Operating Characteristic (ROC) curve for prediction of postoperative liver dysfunction at ≤ 68.95% ASGPR+ hepatocytes achieved a sensitivity of 100% and specificity of 90.6%. The ROC curve for prediction of postoperative liver failure related death at ≤ 58.53% ASGPR+ hepatocytes achieved a sensitivity of 100% and specificity of 99%.
Flow cytometric assessment of ASGPR expression may be a useful predictor of liver dysfunction following major hepatectomy for HCC in Chinese patients.
验证一种更便宜且更易获得的基于流式细胞术的评估去唾液酸糖蛋白受体(ASGPR)表达以评估肝功能储备的方法。
回顾性分析。
2011年1月至2013年10月,首都医科大学附属北京地坛医院。
对研究期间在北京地坛医院接受大肝切除术的肝细胞癌(HCC)患者进行回顾性研究。通过流式细胞术评估肝组织中表达ASGPR的肝细胞比例。根据术后肝功能障碍的有无对患者进行分组。分析ASGPR表达与术前肝功能参数和肝切除术后结果之间的相关性。
术后出现肝功能障碍的患者中表达ASGPR的肝细胞[63.3(57.3 - 68.2)]比未出现术后肝功能障碍的患者[72.4(70.6 - 76.3)]少,p < 0.001。多因素logistic回归显示ASGPR水平与术后肝功能障碍独立相关(优势比3.34,95%CI:2.61 - 6.02,p < 0.001),预测术后肝功能障碍时ASGPR + 肝细胞≤68.95%的受试者工作特征(ROC)曲线灵敏度为100%,特异度为90.6%。预测术后肝衰竭相关死亡时ASGPR + 肝细胞≤58.53%的ROC曲线灵敏度为100%,特异度为99%。
流式细胞术评估ASGPR表达可能是中国HCC患者大肝切除术后肝功能障碍的有用预测指标。